Skip to main content
Caplight Logo









EntoGreen

EntoGreen

Private
SantarémEnergy & Sustainabilityhttps://entogreen.com

Last Round

Debt

Jul 11, 2022

Total Funding Raised

$4.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EntoGreen operates in Energy & Sustainability and is based in Santarém. Its latest recorded funding round was a Debt round in July 2022.

EntoGreen is an agricultural biotechnology company that produces sustainable animal protein and organic fertilizers by upcycling agri-food industry by-products using black soldier fly larvae.

Sector

Energy & Sustainability

Verticals

Circular Economy, Biotechnology, Waste Management, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EntoGreen Comparables

Compare EntoGreen with similar companies based on industry and business-model similarity.

EntoGreen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hexafly
91%
Bioflytech
89%
Protix
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EntoGreen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 11, 2022
Series AMar 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EntoGreen Investors

Notable investors and investment history

EntoGreen investors
InvestorRounds
BlueCrow CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2026

    Monthly visitors grew 32% MoM.

  • Aug 3, 2026

    Open roles increased to 6, 3x the trailing average.

Book a demo to see all signals

For institutional investors. Book with your work email.

EntoGreen Filings

Explore SEC and related filing metadata, where available.

EntoGreen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EntoGreen's valuation, stock price, and market status.

Is EntoGreen a public or private company?

EntoGreen is a private company.

What is the current stock price of EntoGreen?

EntoGreen is a private company, so its shares have no public market price. Caplight tracks EntoGreen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EntoGreen worth (valuation)?

Valuation information for EntoGreen is not publicly available.

Can I buy EntoGreen stock?

EntoGreen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EntoGreen's last funding round?

EntoGreen's most recent funding round was Debt on July 11, 2022.

Who are the main investors in EntoGreen?

Key investors in EntoGreen include BlueCrow Capital.

Will EntoGreen IPO soon?

No public IPO plans have been announced for EntoGreen.

How can I track EntoGreen secondary market activity?

Caplight tracks bids, offers, and trades in EntoGreen's shares on secondary markets.

Firmographic Details

HeadquartersSantarém
Employee Range19
Year Founded2014
Last FundingJul 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?